Ads
related to: target
Search results
TARGET 8: Two deadly incidents highlight lack of clear policy for crisis intervention by Columbia...
KOMU Columbia· 2 hours agoA colorful Calavera, which is a skull candy that symbolizes the Mexican holiday “Day of the Dead,”...
BofA raises Hims & Hers shares target in light of GLP-1 opportunity By Investing.com
Investing.com· 12 hours agoOn Monday, BofA Securities increased its price target for Hims & Hers Health, Inc. (NYSE:HIMS)...
Are Investors Undervaluing Neuren Pharmaceuticals Limited (ASX:NEU) By 46%?
Simply Wall St. via Yahoo Finance· 1 hour ago...fair value is AU$37.87 based on 2 Stage Free Cash Flow to Equity Current share price of AU$20.27...
Imerys shares target lifted by Berenberg amid strong joint venture earnings By Investing.com
Investing.com· 14 hours agoOn Monday, Berenberg increased its price target on Imerys SA (NK:FP) (OTC: IMYSF) shares to €45.00...
ConocoPhillips shares target raised by Truist on MRO deal accretion By Investing.com
Investing.com· 12 hours agoOn Monday, Truist Securities increased its price target for ConocoPhillips (NYSE:COP) shares to $165...
Deutsche raises Hilton Grand Vacations shares target, highlights acquisition synergies By...
Investing.com· 13 hours agoOn Monday, Deutsche Bank (ETR:DBKGn) increased its price target for shares of Hilton Grand Vacations...
RCN warns of declining numbers starting nursing degree courses
Press Association News via AOL· 29 minutes agoThe official NHS workforce plan for England will be almost 11,000 new nurses behind target by 2025...
Cyclacel Pharmaceuticals maintains $11 target, Buy rating By Investing.com
Investing.com· 6 hours agoOn Monday, Roth/MKM maintained its Buy rating and $11.00 price target for Cyclacel Pharmaceuticals...
Murphy USA stock target trimmed on first quarter results miss By Investing.com
Investing.com· 7 hours agoOn Monday, JPMorgan made an adjustment to Murphy USA's (NYSE:MUSA) price target, bringing it down...
Citi sets Sensei Biotherapeutics stock to buy with $4 target By Investing.com
Investing.com· 5 hours agoOn Monday, Citi resumed coverage of Sensei Biotherapeutics (NASDAQ:SNSE) with a Buy rating, and a...